BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 239460)

  • 1. The activation of human factor IX.
    Osterud B; Laake K; Prydz H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):553-63. PubMed ID: 239460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma.
    Tans G; Janssen-Claessen T; van Dieijen G; Hemker HC; Rosing J
    Thromb Haemost; 1982 Oct; 48(2):127-32. PubMed ID: 6983739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human factor IX (Christmas factor).
    Di Scipio RG; Kurachi K; Davie EW
    J Clin Invest; 1978 Jun; 61(6):1528-38. PubMed ID: 659613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
    Osterud B; Rapaport SI
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5260-4. PubMed ID: 271951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redetermination of the rate-limiting step in the activation of factor IX by factor XIa and by factor VIIa/tissue factor. Explanation for different electrophoretic radioactivity profiles obtained on activation of 3H- and 125I-labeled factor IX.
    Bajaj SP; Rapaport SI; Russell WA
    Biochemistry; 1983 Aug; 22(17):4047-53. PubMed ID: 6604546
    [No Abstract]   [Full Text] [Related]  

  • 7. Cleavage and activation of human factor IX by serine proteases.
    Enfield DL; Thompson AR
    Blood; 1984 Oct; 64(4):821-31. PubMed ID: 6383497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of bovine factor IX (Christmas factor) by factor XIa (activated plasma thromboplastin antecedent) and a protease from Russell's viper venom.
    Lindquist PA; Fujikawa K; Davie EW
    J Biol Chem; 1978 Mar; 253(6):1902-9. PubMed ID: 632245
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological control of factor VII.
    Nemerson Y
    Thromb Haemost; 1976 Feb; 35(1):96-100. PubMed ID: 989197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
    Saito H; Ratnoff OD; Marshall JS; Pensky J
    J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of purified plasma factor VII by human plasmin, plasma kallikrein, and activated components of the human intrinsic blood coagulation system.
    Laake K; Osterud B
    Thromb Res; 1974 Dec; 5(6):759-72. PubMed ID: 4280635
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
    Schapira M; Scott CF; Colman RW
    Trans Assoc Am Physicians; 1981; 94():190-7. PubMed ID: 6979819
    [No Abstract]   [Full Text] [Related]  

  • 18. Snake venom proteinase inhibitors. I. Isolation and properties of two inhibitors of kallikrein, trypsin, plasmin, and alpha-chymotrypsin from the venom of Russell's viper (Vipera russelli).
    Takahashi H; Iwanaga S; Suzuki T
    J Biochem; 1974 Oct; 76(4):709-19. PubMed ID: 4279913
    [No Abstract]   [Full Text] [Related]  

  • 19. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
    Bajaj SP; Rapaport SI; Maki SL; Brown SF
    Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface adsorption of factor XI. Association of adsorption sites with the heavy chain of activated factor XI.
    Mannhalter C; Schiffman S
    Thromb Haemost; 1980 Jun; 43(2):124-6. PubMed ID: 7455969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.